Critical Medicines Act: New measures to tackle shortages and strengthen supply security
Council of the EU & European Parliament
|
December 17 2025
The new rules incentivise supply chain diversification, support collaborative procurement models and create incentives to boost pharmaceutical manufacturing in EU countries. On 2 December, the Council agreed its position, and on 15 December, the European Parliament’s public health committee adopted its proposals to enhance the availability of key medicines in the EU. Parliament’s position is expected to be adopted during the January 2026 plenary session, after which the two institutions will enter into negotiations to agree on the final text.
Share
Topics
NCD / Risk Groups
Mediums
